AI platform combined with autonomous labs will accelerate discovery across every domain of science Company has raised $200M in seed financing to further develop platform and build first AI Science Factories CAMBRIDGE, MA – Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company building the world’s first scientific superintelligence platform and fully […]
PARIS — GenBio AI, a leading company at the intersection of AI and biology, is excited to announce that Dr. Ziv Bar-Joseph has joined as Co-founder and Chief Scientific Officer. In this role, Bar-Joseph will lead work focused on the integration and use of GenBio AI’s multiscale foundation models, ensuring they drive real impact in drug discovery, […]
Gene structure information identified by combining Compugen’s AI/ML predictive computational discovery platform, Unigen™ with Ultima’s UG 100™ sequencing platform to better understand tumor biology and immune regulation Leveraging Compugen’s computational analytical tools uncovered high consistency in single-cell expression levels across Ultima’s UG 100 sequencing platform, offering a potential advantage for demarcation of transcript termination. Research presented at […]
OPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing applications MSK-ACCESS® powered with SOPHiA DDM™ and MSK-IMPACT® powered with SOPHiA DDM™. Thirty-seven prominent institutions, including top researchers […]
WALTHAM, Mass. — Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce Revvity’s rights under its agreements with Cloud Software Group (CSG) related to the Spotfire® software. This ruling follows a preliminary injunction issued in April 2024, which will become permanent, ensuring uninterrupted access […]
DKSH has received Global ISO certifications for environmental practices (ISO 14001) as well as occupational health and safety (ISO 45001) across multiple markets. This achievement reinforces DKSH’s commitment to sustainability and safety in its supply chains, which are continuously improved. DKSH aims to extend these ISO certifications to other key markets in the future. Zurich, […]
SAN DIEGO, CALIFORNIA — Rancho BioSciences, the premier tech-enabled data science partner for biopharma, welcomes Bristol Myers Squibb (BMS) back for the 2nd phase of The Single-Cell Data Science Consortium. This continuing initiative aims to build on Phase 1’s foundation, bringing together leading pharmaceutical companies with shared goals and needs in the realm of single-cell data. […]
Today, BC Platforms (BCP), a global leader in real-world data (RWD), healthcare data management, and analytics, announces the appointment of Mukhtar Ahmed as its new Chief Executive Officer, effective February 17th, 2025. Over his 30-year career, Mukhtar has served on the boards of the National Health Service (NHS) and several venture capital and private equity-funded companies. He was […]
New facility reflects QIAGEN’s commitment to enhancing its bioinformatics data center infrastructure in the Australia, New Zealand, New Guinea and surrounding islands region New data center in Melbourne meets Australian regulations to ensure quality, scalable and trustworthy support for Omics analysis and interpretation in genomic testing labs Expands a QIAGEN network of seven data centers […]
Data on CYP27A1 Variants Available to Genetic Testing Labs Around the World Ann Arbor, MI – Genomenon, Inc., a leading provider of genomic intelligence solutions, has announced a strategic partnership with Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) to improve the awareness and diagnosis of Cerebrotendinous Xanthomatosis (CTX).The collaboration will focus on CYP27A1 gene variants, making critical genetic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
